Section 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Section 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
Section 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTER’S FIVE FORCES ANALYSIS
3.4. GOVERNMENT REGULATION
3.4.1. U.S. FDA
3.4.2. Europe CE Mark
3.4.3. Ministry of Health, Labor, and Welfare (MHLW)
3.5. REIMBURSEMENT SCENARIO
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Increase in funding for improved dialysis products and services
3.6.1.2. Increase in the number of ESRD patients
3.6.1.3. Rise in incidence of diabetes and hypertension
3.6.1.4. Shortage of kidneys for transplantation
3.6.2. Restraints
3.6.2.1. Risks and complications associated with dialysis
3.6.2.2. Product recall
3.6.3. Opportunities
3.6.3.1. Technological Advancements Leading to Better Adoption
3.6.3.2. Rise in the demand for home peritoneal dialysis treatment
3.6.3.3. Untapped Markets in Developing Economies
Section 4 DIALYSIS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. HEMODIALYSIS
4.2.1. Market size and forecast
4.2.2. Conventional hemodialysis
4.2.2.1. Market size and forecast
4.2.3. Short daily hemodialysis
4.2.3.1. Market size and forecast
4.2.4. Nocturnal hemodialysis
4.2.4.1. Market size and forecast
4.3. PERITONEAL DIALYSIS
4.3.1. Market size and forecast
4.3.2. Continuous Ambulatory Peritoneal Dialysis (CAPD)
4.3.2.1. Market size and forecast
4.3.3. Automated Peritoneal Dialysis (APD)
4.3.3.1. Market size and forecast
Section 5 DIALYSIS MARKET, BY PRODUCTS AND SERVICES
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. EQUIPMENT
5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. Dialysis Machines
5.2.4.1. Market size and forecast
5.2.5. Water Treatment Systems
5.2.5.1. Market size and forecast
5.2.6. Others dialysis equipment
5.2.6.1. Market size and forecast
5.3. CONSUMABLES
5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Dialyzers
5.3.4.1. Market size and forecast
5.3.5. Catheters
5.3.5.1. Market size and forecast
5.3.6. Other dialysis consumables
5.3.6.1. Market size and forecast
5.4. DIALYSIS DRUGS
5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast
5.5. SERVICES
5.5.1. Key market trends
5.5.2. Growth factors and opportunities
5.5.3. Market size and forecast
Section 6 DIALYSIS MARKET, BY END-USERS
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. IN-CENTER DIALYSIS
6.2.1. Market size and forecast
6.3. HOME DIALYSIS
6.3.1. Market size and forecast
Section 7 DIALYSIS MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.3.1. U.S.: Market size and forecast
7.2.3.2. Mexico: Market size and forecast
7.2.3.3. Canada: Market size and forecast
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.3.1. Germany: Market size and forecast
7.3.3.2. France: Market size and forecast
7.3.3.3. UK: Market size and forecast
7.3.3.4. Italy: Market size and forecast
7.3.3.5. Spain: Market size and forecast
7.3.3.6. Rest of Europe: Market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.3.1. Japan: Market size and forecast
7.4.3.2. China: Market size and forecast
7.4.3.3. Australia: Market size and forecast
7.4.3.4. India: Market size and forecast
7.4.3.5. South Korea: Market size and forecast
7.4.3.6. Taiwan: Market size and forecast
7.4.3.7. Rest of Asia-Pacific: Market size and forecast
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.3.1. Brazil market size and forecast
7.5.3.2. South Africa: Market size and forecast
7.5.3.3. Saudi Arabia: Market size and forecast
7.5.3.4. Rest of LAMEA: Market size and forecast
Section 8 COMPANY PROFILE
8.1. ASAHI KASEI CORPORATION
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. B. BRAUN MELSUNGEN AG
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. BAXTER INTERNATIONAL INC.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. DAVITA INC.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. DIAVERUM DEUTSCHLAND GMBH.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. diaverum: Key strategic moves and developments
8.6. FRESENIUS MEDICAL CARE AG & CO.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. MEDIVATORS, INC.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. NIKKISO CO. LTD.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. NIPRO CORPORATION
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. NXSTAGE MEDICAL, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments